Source: Central Nervous System Agents in Medicinal Chemistry. Unidades: FCFRP, FFCLRP
Subjects: FARMACOCINÉTICA, DOENÇA DE PARKINSON, PLANEJAMENTO DE FÁRMACOS, FÁRMACOS (SISTEMA NERVOSO CENTRAL), RESULTADO DE TRATAMENTO
ABNT
SOUZA, Lucilene R. et al. Theoretical study of monoamine oxidase B inhibitors as drug candidates for treatment of Parkinson’s disease. Central Nervous System Agents in Medicinal Chemistry, v. 20, n. 2, p. 128-143, 2020Tradução . . Disponível em: https://doi.org/10.2174/1871524920666200217110211. Acesso em: 07 set. 2024.APA
Souza, L. R., Picanço, L. C. S., Brito, M. F. B., Almeida, M. R. S., Marino, B. L. B., Sousa, K. P. A., et al. (2020). Theoretical study of monoamine oxidase B inhibitors as drug candidates for treatment of Parkinson’s disease. Central Nervous System Agents in Medicinal Chemistry, 20( 2), 128-143. doi:10.2174/1871524920666200217110211NLM
Souza LR, Picanço LCS, Brito MFB, Almeida MRS, Marino BLB, Sousa KPA, Ferreira JV, Santos CBR, Silva GM da, Silva CHT de P da, Taft CA, Melim LI da SH. Theoretical study of monoamine oxidase B inhibitors as drug candidates for treatment of Parkinson’s disease [Internet]. Central Nervous System Agents in Medicinal Chemistry. 2020 ; 20( 2): 128-143.[citado 2024 set. 07 ] Available from: https://doi.org/10.2174/1871524920666200217110211Vancouver
Souza LR, Picanço LCS, Brito MFB, Almeida MRS, Marino BLB, Sousa KPA, Ferreira JV, Santos CBR, Silva GM da, Silva CHT de P da, Taft CA, Melim LI da SH. Theoretical study of monoamine oxidase B inhibitors as drug candidates for treatment of Parkinson’s disease [Internet]. Central Nervous System Agents in Medicinal Chemistry. 2020 ; 20( 2): 128-143.[citado 2024 set. 07 ] Available from: https://doi.org/10.2174/1871524920666200217110211